Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions

Abstract In colorectal cancer (CRC), WNT pathway activation by genetic rearrangements of RSPO3 is emerging as a promising target. However, its low prevalence severely limits availability of preclinical models for in‐depth characterization. Using a pipeline designed to suppress stroma‐derived signal,...

Full description

Bibliographic Details

Published in:	EMBO Molecular Medicine
Main Authors:	Gabriele Picco, Consalvo Petti, Alessia Centonze, Erica Torchiaro, Giovanni Crisafulli, Luca Novara, Andrea Acquaviva, Alberto Bardelli, Enzo Medico
Format:	Article
Language:	English
Published:	Springer Nature 2017-01-01
Subjects:	colorectal cancer gene fusion R‐spondin targeted therapy WNT pathway
Online Access:	https://doi.org/10.15252/emmm.201606773